Eisai Corporation
Eisai Corporation, a prominent player in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1941, Eisai has established itself as a leader in the development of innovative treatments, particularly in neurology and oncology. The company is renowned for its core products, including the Alzheimer's treatment Aricept and the anti-cancer agent Lenvima, both of which showcase Eisai's commitment to addressing unmet medical needs. With a strong focus on research and development, Eisai has achieved significant milestones, including numerous FDA approvals and collaborations that enhance its market position. Eisai's dedication to improving patient outcomes and its strategic initiatives have solidified its reputation as a trusted name in the pharmaceutical sector, making it a key contributor to advancements in healthcare.
DitchCarbon Score
How does Eisai Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eisai Corporation's score of 3 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eisai Corporation's reported carbon emissions
Eisai Corporation, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current impact on climate change or their strategic approach to reducing carbon emissions. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set science-based targets to align with global climate goals. While Eisai Corporation has not disclosed specific emissions data or reduction initiatives, the industry context suggests a growing emphasis on transparency and accountability in environmental performance. As the landscape of corporate climate commitments evolves, it will be essential for Eisai to establish clear targets and report on their emissions to contribute effectively to global efforts in combating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Eisai Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
